Aibotics, Inc. SEC filings AIBT
Aibotics, Inc. has 110 filings in SEC EDGAR's recent list, going back to Jan 31, 2019. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (material agreement, acquisition or sale of assets). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Oct 16, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 5, 2026 | Oct 2, 2026 |
| 10-Q | Quarterly report | Aug 19, 2026 | Jun 30, 2026 |
| NT 10-Q | Form nt 10-q filing | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Jun 9, 2026 | Mar 31, 2026 |
| NT 10-Q | Form nt 10-q filing | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Apr 15, 2026 | Dec 31, 2025 |
| NT 10-K | Aibotics, inc.- nt10k | Mar 31, 2026 | Dec 31, 2025 |
| S-8 | Employee stock plan registration | Jan 28, 2026 | — |
| 10-Q | Quarterly report | Nov 19, 2025 | Sep 30, 2025 |
| NT 10-Q | Form nt 10-q filing | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 19, 2025 | Jun 30, 2025 |
| NT 10-Q | Form nt 10-q filing | Aug 14, 2025 | Jun 30, 2025 |
| 253G2 | Aibotics form 253(g)(2) | Jul 3, 2025 | — |
| QUALIF | Filing | Jul 1, 2025 | — |
| CORRESP | Letter to the SEC | Jun 27, 2025 | — |
| 1-A/A | Filing | Jun 27, 2025 | — |
| CORRESP | Letter to the SEC | Jun 24, 2025 | — |
| 1-A/A | Filing | Jun 2, 2025 | — |
| CORRESP | Letter to the SEC | May 29, 2025 | — |
| 1-A/A | Filing | May 29, 2025 | — |
| UPLOAD | Letter from the SEC | May 20, 2025 | — |
| 10-Q | Quarterly report | May 20, 2025 | Mar 31, 2025 |
| NT 10-Q | Aibotics, inc. - nt 10-q | May 15, 2025 | Mar 31, 2025 |
| 1-A/A | Filing | May 7, 2025 | — |
| 10-K | Annual report | Apr 11, 2025 | Dec 31, 2024 |
| UPLOAD | Letter from the SEC | Apr 3, 2025 | — |
| 1-A | Filing | Apr 2, 2025 | — |
| NT 10-K | Aibotics, inc. form 12b25 | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 24, 2025 | Jan 25, 2025 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| S-8 | Employee stock plan registration | Sep 13, 2024 | — |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Aug 21, 2024 | Jul 29, 2024 |
| 10-Q | Quarterly report | Aug 19, 2024 | Jun 30, 2024 |
| NT 10-Q | Mycotopia therapies, inc. - nt10q | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 10-K | Annual report | Apr 23, 2024 | Dec 31, 2023 |
| NT 10-K | Mycotopia therapies - nt10k | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Auditor change
|
Mar 28, 2024 | Mar 21, 2024 |
| DEF 14C | Information statement | Mar 18, 2024 | Mar 15, 2024 |
| PRE 14C | Mycotopia therapies - pre14c | Jan 29, 2024 | Jan 29, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Dec 5, 2023 | Nov 28, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 10-K/A | Amended annual report | Nov 6, 2023 | Dec 31, 2022 |
| 10-Q/A | Amended quarterly report | Nov 6, 2023 | Sep 30, 2022 |
| 10-Q/A | Amended quarterly report | Oct 17, 2023 | Jun 30, 2022 |
| 10-Q/A | Amended quarterly report | Oct 17, 2023 | Mar 31, 2022 |
| 10-K/A | Amended annual report | Oct 17, 2023 | Dec 31, 2021 |
| 10-Q | Quarterly report | Aug 17, 2023 | Jun 30, 2023 |
| NT 10-Q | Mycotopia therapies, inc.- nt10-q | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | Jul 14, 2023 | Mar 31, 2023 |
| NT 10-Q | Mycotopia therapies, inc.- nt10-q | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Restatement
|
May 3, 2023 | Apr 25, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Feb 22, 2023 | Feb 16, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 23, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 19, 2022 | May 18, 2022 |
| NT 10-Q | Mycotopia therapies, inc. (form: nt 10-q) | May 17, 2022 | Mar 31, 2022 |
| 10-K | Annual report | Apr 14, 2022 | Dec 31, 2021 |
| NT 10-K | Mycotopia therapies, inc..form: nt 10-k | Apr 5, 2022 | Dec 31, 2021 |
| NT 10-K | Mycotopia therapies, inc..form: nt 10-k | Mar 31, 2022 | Mar 31, 2021 |
| QUALIF | Filing | Jan 18, 2022 | — |
| 8-K |
Current report
Material agreement
|
Jan 14, 2022 | Nov 17, 2021 |
| CORRESP | Letter to the SEC | Jan 14, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 14, 2022 | — |
| 1-A | Filing | Jan 6, 2022 | — |
| 10-Q | Quarterly report | Nov 19, 2021 | Sep 30, 2021 |
| NT 10-Q | Mycotopia therapies, inc. (form: nt 10-q) | Nov 17, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 20, 2021 | Jun 30, 2021 |
| NT 10-Q | Mycotopia therapies, inc. (form: nt 10-q) | Aug 16, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 20, 2021 | Mar 31, 2021 |
| NT 10-Q | Mycotopia therapies, inc. (form: nt 10-q) | May 19, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Apr 15, 2021 | Dec 31, 2020 |
| UPLOAD | Letter from the SEC | Apr 6, 2021 | — |
| NT 10-K | 20/20 global, inc. - form nt 10k | Apr 1, 2021 | Dec 31, 2020 |
| 8-K/A |
Amended current report
Acquisition or sale of assets, Change in control, Officer or director change
|
Mar 30, 2021 | Jan 19, 2021 |
| SC 14F1 | 20/20 global sch 14f-1 | Feb 9, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 2, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 21, 2021 | Jan 20, 2021 |
| 8-K |
Current report
Acquisition or sale of assets, Change in control, Officer or director change
|
Jan 20, 2021 | Jan 19, 2021 |
| 8-K |
Current report
Material agreement
|
Jan 6, 2021 | Jan 4, 2021 |
| 8-K |
Current report
Material agreement, Change in control, Officer or director change
|
Dec 29, 2020 | Dec 24, 2020 |
| 10-Q | Quarterly report | Nov 16, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 19, 2020 | Jun 30, 2020 |
| NT 10-Q | Filing | Aug 14, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 18, 2020 | Mar 31, 2020 |
| NT 10-Q | 20/20 global, inc. nt 10-q | May 15, 2020 | Mar 31, 2020 |
| 10-K | Annual report | Mar 30, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
Mar 11, 2020 | Mar 6, 2020 |
| 8-K |
Current report
Other events
|
Dec 31, 2019 | Dec 27, 2019 |
| 10-Q | Quarterly report | Nov 14, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 16, 2019 | Jun 30, 2019 |
| NT 10-Q | Filing | Aug 15, 2019 | Jun 30, 2019 |
| UPLOAD | Letter from the SEC | Jun 13, 2019 | — |
| 10-12G/A | Filing | Jun 10, 2019 | — |
| CORRESP | Letter to the SEC | May 29, 2019 | — |
| 10-12G/A | Filing | May 29, 2019 | — |
| UPLOAD | Letter from the SEC | May 7, 2019 | — |
| 10-12G | Filing | Apr 15, 2019 | — |
| RW | Filing | Mar 15, 2019 | — |
| 10-12G | Form 10 | Jan 31, 2019 | — |
Showing 103 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- AIBT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Heyburn, ID
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1763329
- Former names
- Mycotopia Therapies, Inc. (until Dec 17, 2024); 20/20 Global, Inc. (until May 19, 2021)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.